Gene · 7516
Papers1,770
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 1,770
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| B4GALNT2 Gene Promotes Proliferation, and Invasiveness and Migration Abilities of Model Triple Negative Breast Cancer (TNBC) Cells by Interacting With HLA-B Protein. | Front Oncol | 2021 | 34589428 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Prognostic and Immune Infiltrates for RAD51 in Human Breast Cancer. | Crit Rev Eukaryot Gene Expr | 2021 | 34587437 | PubTator, text mining | PubMed |
| Two new cases of interstitial 7q35q36.1 deletion including CNTNAP2 and KMT2C. | Mol Genet Genomic Med | 2021 | 34582124 | PubTator, text mining | PubMed |
| The Role of the Rad55-Rad57 Complex in DNA Repair. | Genes (Basel) | 2021 | 34573372 | PubTator, text mining | PubMed |
| miR-27b-3p a Negative Regulator of DSB-DNA Repair. | Genes (Basel) | 2021 | 34573315 | PubTator, text mining | PubMed |
| Determinants of Homologous Recombination Deficiency in Pancreatic Cancer. | Cancers (Basel) | 2021 | 34572943 | PubTator, text mining | PubMed |
| Transcriptome of Male Breast Cancer Matched with Germline Profiling Reveals Novel Molecular Subtypes with Possible Clinical Relevance. | Cancers (Basel) | 2021 | 34572741 | PubTator, text mining | PubMed |
| Recent advances in testicular germ cell tumours. | Fac Rev | 2021 | 34557871 | PubTator, text mining | PubMed |
| Nucleotide proofreading functions by nematode RAD51 paralogs facilitate optimal RAD51 filament function. | Nat Commun | 2021 | 34545070 | PubTator, text mining | PubMed |
| Significant value of XRCC2 and XRCC9 expression in the prognosis of human ovarian carcinoma. | J Cancer | 2021 | 34539898 | PubTator, text mining | PubMed |
| Clear Cell Papillary Renal Cell Carcinoma Shares Distinct Molecular Characteristics and may be Significantly Associated With Higher Risk of Developing Second Primary Malignancy. | Pathol Oncol Res | 2021 | 34512202 | PubTator, text mining | PubMed |
| REV1-Polζ maintains the viability of homologous recombination-deficient cancer cells through mutagenic repair of PRIMPOL-dependent ssDNA gaps. | Mol Cell | 2021 | 34508659 | PubTator, text mining | PubMed |
Pim kinase inhibitor co-treatment decreases alternative non-homologous end-joining DNA repair and genomic instability induced by topoisomerase 2 inhibitors in cells with FLT3 internal tandem duplication. | Oncotarget | 2021 | 34504649 | PubTator, text mining | PubMed |
| Breast Cancer-Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies-An Updated Review. | Cancers (Basel) | 2021 | 34503097 | PubTator, text mining | PubMed |
| Targeting DNA Damage Repair Mechanisms in Pancreas Cancer. | Cancers (Basel) | 2021 | 34503069 | PubTator, text mining | PubMed |
| Genomics and metabolomics of early-stage thioacetamide-induced liver injury: An interspecies study between guinea pig and rat. | Toxicol Appl Pharmacol | 2021 | 34492290 | PubTator, text mining | PubMed |
| Translational models of 3-D organoids and cancer stem cells in gastric cancer research. | Stem Cell Res Ther | 2021 | 34488885 | PubTator, text mining | PubMed |
| TAZ maintains telomere length in TNBC cells by mediating Rad51C expression. | Breast Cancer Res | 2021 | 34488828 | PubTator, text mining | PubMed |
| Gene expression and prognosis of x-ray repair cross-complementing family members in non-small cell lung cancer. | Bioengineered | 2021 | 34486486 | PubTator, text mining | PubMed |
| Correlation analysis between XRCC2 polymorphism and radiosensitivity of non-small cell lung cancer. | Panminerva Med | 2021 | 34486365 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7516/papers?page=24